| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42001066 | EBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS10007481 | HBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS10019784 | HBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS10034059 | HBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS10034682 | HBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS10037036 | HBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS10034688 | HBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS10020501 | HBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS10041124 | HBV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
| TVIS30085194 | HIV | ENSG00000112541.19 | protein_coding | PDE10A | No | No | 10846 | A0A1B1UZR0 Q9Y233 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PDE10A |
|---|---|
| DrugBank ID | DB00975 |
| Drug Name | Dipyridamole |
| Target ID | BE0000631 |
| UniProt ID | Q9Y233 |
| Regulation Type | inhibitor |
| PubMed IDs | 17139284; 17016423; 10373451 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Fujishige K, Kotera J, Michibata H, Yuasa K, Takebayashi S, Okumura K, Omori K: Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J Biol Chem. 1999 Jun 25;274(26):18438-45. |
| Groups | Approved |
| Direct Classification | Dialkylarylamines |
| SMILES | OCCN(CCO)C1=NC2=C(N=C(N=C2N2CCCCC2)N(CCO)CCO)C(=N1)N1CCCCC1 |
| Pathways | Dipyridamole (Antiplatelet) Action Pathway |
| PharmGKB | PA449367 |
| ChEMBL | CHEMBL932 |
